Reply to Comments by Dr Peng et al for "Pharmacokinetics Study for Hyperprolactinemia Among Schizophrenics Switched from Risperidone to Risperidone Long-Acting Injection"
Authors:
- Ya Mei BaiYBYa Mei Bai
- Tzu Ting ChenTCTzu Ting Chen
- Wen Kuo LinWLWen Kuo Lin
- Wen-Ho ChangWCWen-Ho Chang
- Chih Hung HungCHChih Hung Hung
- Jen-Yeu ChenJCJen-Yeu Chen
- 1 December 2008
- journal article
- letter
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 28 (6) , 727-728
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The Disparity of Pharmacokinetics and Prolactin Study for Risperidone Long-Acting InjectionJournal of Clinical Psychopharmacology, 2008
- Equivalent Switching Dose From Oral Risperidone to Risperidone Long-Acting InjectionThe Journal of Clinical Psychiatry, 2007
- The use of electronic monitoring (MEMS®) to evaluate antipsychotic compliance in outpatients with schizophreniaSchizophrenia Research, 2007
- Effectiveness of Antipsychotic Drugs in Patients with Chronic SchizophreniaNew England Journal of Medicine, 2005
- A Trial of Compliance Therapy in Outpatients With Schizophrenia or Schizoaffective DisorderThe Journal of Clinical Psychiatry, 2005
- Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapiesInternational Clinical Psychopharmacology, 2005
- Comparative efficacy and safety of long-acting risperidone and risperidone oral tabletsEuropean Neuropsychopharmacology, 2005
- Pharmacokinetics and tolerability of long-acting risperidone in schizophreniaSchizophrenia Research, 2004
- Treatment of Schizophrenia With Long-Acting Injectable RisperidoneThe Journal of Clinical Psychiatry, 2003
- Elevation of Prolactin Levels by Atypical AntipsychoticsAmerican Journal of Psychiatry, 2002